Log in

Start free trial
Home 5 Clinical Diagnostics Insider 5 How PAMA’s Effect in 2018 Molecular Diagnostic Reimbursement Will Make Labs More Money

How PAMA’s Effect in 2018 Molecular Diagnostic Reimbursement Will Make Labs More Money

by | Jun 25, 2018 | Clinical Diagnostics Insider, Coding-lca, Compliance-lca, Fee Schedules-lir, Fee Schedules-nir, Reimbursement-dtet, Reimbursement-lir, Reimbursement-nir

By Sean McSweeney  bio The year 2018 is slated to be much brighter for molecular diagnostic labs as PAMA fee schedules show a higher payment rate and amount for many cancer genomics and… . . . read more

iStock, metamorworks

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article

TRY FOR FREE